Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Global
News

‘Iran atomic facility substantially damaged in attack’ -Earlier Report From Jerusalem Post

https://www.jpost.com/middle-east/drone-attack-targets-irans-atomic-energy-organization-671834

byMichael Horton

June 23, 2021

1 minute read

https://www.jpost.com/middle-east/drone-attack-targets-irans-atomic-energy-organization-671834

Qualcomm Chief Sees Prospects In High-End Smartphones, Meta Partnership Thanks To Augmented and Virtual Reality

By Anusuya Lahiri

May 26, 8:33 AM

In an interview at the World Economic Forum, Qualcomm Inc (NASDAQ:QCOM) CEO Cristiano Amon talked about growth as consumers increasingly…

Agile Therapeutics, Afaxys Report Partnership To Expand Access To Twirla Transdermal System, No Terms Disclosed

By Benzinga Newsdesk

January 10, 9:05 AM

Agile Therapeutics, Inc. (NASDAQ:AGRX), a women's healthcare company, today announced a new alliance with Afaxys Pharma, LLC to promote Twirla® (levonorgestrel and ethinyl estradiol) transdermal

AGRX

JP Morgan Maintains Overweight on BTRS Holdings, Lowers Price Target to $8

By Benzinga Newsdesk

March 2, 11:17 AM

JP Morgan analyst Tien-Tsin Huang maintains BTRS Holdings (NASDAQ:BTRS) with a Overweight and lowers the price target from $15 to $8.

BTRS

Baird Initiates Coverage On Toast with Outperform Rating, Announces Price Target of $25

By Benzinga Newsdesk

March 15, 4:57 AM

Baird analyst David Koning initiates coverage on Toast (NYSE:TOST) with a Outperform rating and announces Price Target of $25.

TOST

‘Iran atomic facility substantially damaged in attack’ -Earlier Report From Jerusalem Post

Related Posts

Qualcomm Chief Sees Prospects In High-End Smartphones, Meta Partnership Thanks To Augmented and Virtual Reality

Agile Therapeutics, Afaxys Report Partnership To Expand Access To Twirla Transdermal System, No Terms Disclosed

JP Morgan Maintains Overweight on BTRS Holdings, Lowers Price Target to $8

Baird Initiates Coverage On Toast with Outperform Rating, Announces Price Target of $25